Search

In order to further reveal the differences of association between body mass index (BMI) and cancer incidence across populations, genders, and menopausal status, we performed comprehensive meta-analysis with eligible citations. The risk ratio (RR) of incidence at 10 different cancer sites (per 5kg/m(2) increase in BMI) were quantified separately by employing generalized least-squares to estimate trends, and combined by meta-analyses. We observed significantly stronger association between increased BMI and breast cancer incidence in the Asia-Pacific group (RR 1.18:1.11-1.26) than in European-Australian (1.05:1.00-1.09) and North-American group (1.06:1.03-1.08) (meta-regression p<0.05). No association between increased BMI and pancreatic cancer incidence (0.94:0.71-1.24) was shown in the Asia-Pacific group (meta-regression p<0.05), whereas positive associations were found in other two groups. A significantly higher RR in men was found for colorectal cancer in comparison with women (meta-regression p<0.05). Compared with postmenopausal women, premenopausal women displayed significantly higher RR for ovarian cancer (pre- vs. post-=1.10 vs. 1.01, meta-regression p<0.05), but lower RR for breast cancer (pre- vs. post-=0.99 vs. 1.11, meta-regression p<0.0001). Our results indicate that overweight or obesity is a strong risk factor of cancer incidence at several cancer sites. Genders, populations, and menopausal status are important factors effecting the association between obesity and cancer incidence for certain cancer types. [ABSTRACT FROM AUTHOR]

Regulators in Australia and China are increasingly embracing RegTech. 'RegTech' is a contraction of the terms 'regulatory' and 'technology'. The term describes the use of technology to help companies comply with regulation and help regulators perform their regulatory and supervisory functions. This article identifies various ways that regulators in Australia and China are facilitating RegTech initiatives and categorises and compares those initiatives. The analysis suggests a significant degree of overlap between the two countries in relation to initiatives to facilitate reporting requirements and to improve supervision and supervisory processes. There is a greater focus in China on initiatives to support and strengthen the use of data than in Australia at this stage. However, Australia's regulators are more active in facilitating initiatives to consult and engage with other stakeholders, including other regulators, government and industry. [ABSTRACT FROM AUTHOR]